當前位置：首頁 SCI期刊 SCIE期刊醫學中科院3區 JCRQ2 期刊介紹(非官網)

EndocrineSCIE

國際簡稱：ENDOCRINE 參考譯名：內分泌

中科院分區
3區
CiteScore分區
Q2
JCR分區
Q2

基本信息：: ISSN：1355-008X; E-ISSN：1559-0100; 是否OA：未開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：UNITED STATES; 出版商：Springer US; 出版語言：English; 出版周期：12 issues per year; 出版年份：1995; 研究方向：ENDOCRINOLOGY & METABOLISM

評價信息：: 影響因子：3; H-index：74; CiteScore指數：6.5; SJR指數：0.844; SNIP指數：0.941

發文數據：: Gold OA文章占比：24.97%; 研究類文章占比：80.70%; 年發文量：342; 自引率：0.0540...; 開源占比：0.2095; 出版撤稿占比：0.0026...; 出版國人文章占比：0.17; OA被引用占比：0.1500...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Endocrine期刊介紹

Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.

Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.

Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.

期刊簡介Endocrine期刊介紹

《Endocrine》自1995出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：約1.5月
醫學
ENDOCRINOLOGY & METABOLISM
SCIE
中科院3區
非預警

Cite Score數據（2024年最新版）Endocrine Cite Score數據

CiteScore：6.5
SJR：0.844
SNIP：0.941

學科類別	分區	排名	百分位
大類：Medicine 小類：Endocrinology, Diabetes and Metabolism	Q2	79 / 244	67%
大類：Medicine 小類：Endocrinology	Q2	48 / 128	62%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Endocrine 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	3區	ENDOCRINOLOGY & METABOLISM 內分泌學與代謝	3區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Endocrine JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	88 / 186	53%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	91 / 186	51.34%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
Italy322
CHINA MAINLAND247
USA140
Brazil58
England53
France44
Greece44
GERMANY (FED REP GER)41
Sweden38
Spain37

本刊中國學者近年發表論文

1、Machine learning-based prediction of diagnostic markers for Graves' orbitopathy
Author: Cai, Yunying; Su, Heng; Si, Yongting; Ni, Ninghua

Journal: ENDOCRINE. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12020-023-03349-z
2、Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study
Author: Wang, Shiwei; Wang, Yu; Zhu, Li; He, Liang; Lv, Mutian; Zhang, Hao; Wang, Haoyu; Zhang, Fan; Lai, Yaxin; Li, Yushu; Shan, Zhongyan; Teng, Weiping

Journal: ENDOCRINE. 2023; Vol. 79, Issue 1, pp. 113-124. DOI: 10.1007/s12020-022-03186-6
3、Mutation screening of eight genes and comparison of the clinical data in a Chinese cohort with congenital hypothyroidism
Author: Li, Liangshan; Li, Xiaole; Wang, Xiaoyu; Han, Mengmeng; Zhao, Dehua; Wang, Fang; Liu, Shiguo

Journal: ENDOCRINE. 2023; Vol. 79, Issue 1, pp. 125-134. DOI: 10.1007/s12020-022-03188-4
4、2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease
Author: Parameswaran, Rajeev; de Jong, Mechteld Christine; Kit, James Lee Wai; Sek, Kathleen; Tran Quang Nam; Tran Viet Thang; Nguyen Thy Khue; Than Than Aye; Phone Myint Tun; Cole, Timothy; Miller, Julie A.; Villa, Michael; Khiewvan, Benjapa; Sirinvaravong, Sirinart; Sin, Yong Lit; Muhammad, Rohaizak; Jap, Tjin Shing; Agrawal, Amit; Rajput, Rajesh; Fernando, Ranil; Sumanatilleke, Manilka; Suastika, Ketut; Shong, Young Kee; Lang, Brian; Bartalena, Luigi; Yang, Samantha Peiling

Journal: ENDOCRINE. 2023; Vol. 79, Issue 1, pp. 135-142. DOI: 10.1007/s12020-022-03193-7
5、Global Burden of osteoarthritis associated with high body mass index in 204 countries and territories, 1990-2019: findings from the Global Burden of Disease Study 2019
Author: Zhao, Gaichan; Zhu, Shijie; Zhang, Faxue; Zhang, Xupeng; Zhang, Xiaowei; Li, Tianzhou; Li, Dejia; Zhu, Wei

Journal: ENDOCRINE. 2023; Vol. 79, Issue 1, pp. 60-71. DOI: 10.1007/s12020-022-03201-w
6、Roxadustat improves renal osteodystrophy by dual regulation of bone remodeling
Author: Li, Luyao; Li, Afang; Gan, Liangying; Zuo, Li

Journal: ENDOCRINE. 2023; Vol. 79, Issue 1, pp. 180-189. DOI: 10.1007/s12020-022-03199-1
7、Clinical characteristics and prognostic nomogram for patients with insular thyroid carcinoma: a population-based analysis
Author: Yin, Lei; Hou, Shuang; Hou, Li-Li; Pu, Chen-Chen

Journal: ENDOCRINE. 2023; Vol. 79, Issue 2, pp. 331-341. DOI: 10.1007/s12020-022-03200-x
8、The combination of early identification, chemotherapy, and autologous stem cell transplantation obtained favorable outcomes in unilateral primary adrenal lymphoma: A case report
Author: Huang, Lu; Shuai, Xiao; Zhang, Tingting; Kuang, Pu; Zhang, Dan; Chen, Tao; Tian, Haoming; Xiang, Bing; Ren, Yan

Journal: ENDOCRINE. 2023; Vol. 79, Issue 1, pp. 49-54. DOI: 10.1007/s12020-022-03138-0